Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||acute myeloid leukemia||not applicable||Daunorubicin + VS-II-173||Preclinical - Cell culture||Actionable||In a preclinical study, the combination therapy of Cerubidine (daunorubicin) and VS-II-173 resulted in a synergistic effect in acute myeloid leukemia cells, demonstrating an increase in cell death from 40% to 80% in culture (PMID: 30679386).||30679386|